Can radiation and osimertinib safely control lung cancer spread?
NCT ID NCT05089916
First seen Jan 17, 2026 · Last updated May 14, 2026 · Updated 15 times
Summary
This study looks at whether it is safe to continue the targeted therapy osimertinib while also giving radiation to people with advanced EGFR-positive non-small cell lung cancer. The goal is to manage cancer that has started to grow in a few new spots. Researchers will track side effects and how well the treatment controls the disease in about 42 adults.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
LMU Klinikum der Universität München
München, 80336, Germany
Conditions
Explore the condition pages connected to this study.